Quarterly report pursuant to sections 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.3.0.11
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 6 Months Ended 162 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Net sales         $ 69,000
Cost of goods sold         24,120
Gross profit         44,880
Operating expenses 1,428,251 1,058,433 2,511,235 2,621,969 39,769,189
Research and development expenses 81,213 29,802 552,568 204,095 6,867,282
Non-cash patent settlement costs         1,610,066
Loss before other income (expense) (1,509,464) (1,088,235) (3,063,803) (2,826,064) (48,201,657)
Other income (expense) (26,913)   38,450 5,196 182,422
Interest income         16,342
Interest and financing expense (3,205,280) (1,366,142) (3,796,692) (2,774,021) (15,389,056)
Change in fair value of derivative liabilities 345,987 2,509,892 1,563,584 1,271,129 1,670,249
Costs of private placement       (1,129,212) (1,640,715)
Costs to induce conversion of notes   (168,340)   (168,340) (469,043)
Loss on disposition of equipment         (14,426)
Settlement of Debt Due Morale/Matthews         (927,903)
Settlement of litigation and debt         1,089,088
Loss before provision for income taxes (4,395,670) (112,825) (5,258,461) (5,621,312) (63,684,699)
Provision for income taxes 800   800 800 7,482
Net loss $ (4,396,470) $ (112,825) $ (5,259,261) $ (5,622,112) $ (63,692,181)
Net loss per share, basic and diluted (in Dollars per share) $ (0.04) $ 0.00 $ (0.06) $ (0.07)  
Weighted average common shares outstanding, basic and diluted (in Shares) 100,431,182 81,821,945 91,277,666 77,759,835